Skeletal Physiology Dysregulation in Obesity: The Role of Growth Hormone
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 May 2017
At a glance
- Drugs Somatropin (Primary)
- Indications Metabolic bone diseases; Somatotropin deficiency
- Focus Therapeutic Use
- 08 May 2017 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
- 08 May 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 08 May 2017 Status changed from recruiting to active, no longer recruiting.